Updated Gonorrhea Treatment Recommendations from CDC

Today’s pearl summarizes the recent updates from the CDC’s Treatment Guidelines for Gonococcal Infection.

Which antibiotics and what doses should be used? How do we reach effective concentrations in all patients?
Continue reading “Updated Gonorrhea Treatment Recommendations from CDC”

Antibiotic Effects on Oral Contraceptives

Today’s pearl addresses a misconception regarding a drug interaction between oral contraceptives and antibiotics.

Are back-up methods of contraception required? Does this apply to all antibiotics?
Continue reading “Antibiotic Effects on Oral Contraceptives”

The New Community-Acquired Pneumonia Guidelines are Finally Here!

Today’s pearl is a brief overview the Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS) update to the Adult Community-Acquired Pneumonia (CAP) guidelines, with a focus on medications.

After 12 long years, the highly anticipated update to the CAP guidelines has arrived!
Continue reading “The New Community-Acquired Pneumonia Guidelines are Finally Here!”

Uncomplicated Cellulitis? Consider Strep-only Coverage

Back in 2013, Dr. Pallin’s group in Boston published a study comparing clinical cure rates in uncomplicated cellulitis patients receiving cephalexin or cephalexin plus sulfamethoxazole-trimethoprim (SMX-TMP). I covered this study in a UMEM pearl, with the end result suggesting there was no difference in cure rate between the two treatment arms. Even in communities with high prevalence of MRSA, uncomplicated cellulitis cases without pus or abscess generally seem to be strep species. This was confirmed in the 2014 IDSA guidelines on SSTI in which they recommended streptococcal-only coverage for uncomplicated cases. A new study in JAMA reexamines this treatment strategy.

Continue reading “Uncomplicated Cellulitis? Consider Strep-only Coverage”

Importance of Second Antibiotic Doses in ED Sepsis Patients

Most studies evaluating early antibiotic administration in sepsis patients focus on timing of the first dose. We highlight many of these studies in our recent review article on Appropriate Antibiotic Therapy in Emergency Medicine Clinics of North America. But, what about the second dose? A new study in Critical Care Medicine asks that question. Specifically, what is the frequency and magnitude of delays in second dose in patients admitted from the Emergency Department AND what are the risk factors for these delays?

Continue reading “Importance of Second Antibiotic Doses in ED Sepsis Patients”